Morgan Stanley Pliant Therapeutics, Inc. Call Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
161Shares Held
57.4MCall Options Held
258KPut Options Held
470K-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.59 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.3 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$4.79 Million25.76% of portfolio
-
Blue Owl Capital Holdings LP New York, NY2.97MShares$4.72 Million2.07% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $77.4M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...